Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - Cytosorbents Corptv499518_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - Cytosorbents Corptv499518_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Cytosorbents Corptv499518_ex31-1.htm
10-Q - FORM 10-Q - Cytosorbents Corptv499518_10q.htm

 

Exhibit 32.2

 

CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT of 2002

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Kathleen P. Bloch, the Chief Financial Officer of CytoSorbents Corporation, hereby certify, that, to my knowledge:

 

1. The Quarterly Report on Form 10-Q for the quarter ending June 30, 2018, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in such Quarterly Report on Form 10-Q for the quarter ending June 30, 2018, fairly presents, in all material respects, the financial condition and results of operations of CytoSorbents Corporation.

 

Date: August 2, 2018
 
CYTOSORBENTS CORPORATION

 

By: /s/ Kathleen P. Bloch  

Kathleen P. Bloch

Chief Financial Officer